Product
name: Exendin-4
Synonyms:
GLP-1 receptor
agonist,Exenatide,
CAS
NO.: 141758-74-9
Sequence:
HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS
Modifications:
M.W: 4186.6
M.F.:
C184H282N50O60S
Purity: 95% by
HPLC
Counter
ion: Trifluoacetate
Format: Lyophilized
powder
Description: Exendin-4 (Ex-4), a
long-acting agonist of glucagon-like peptide-1 receptor, is a novel
anti-diabetic drug that prevents ¥â-cells against various toxicities. GLP-1
receptor agonist Ex-4 improves glucose homeostasis, shows antiobesity activity,
without causing harmful side effects like fatty liver.
Uniprot
ID:
Drug Bank
ID: http://www.drugbank.ca/drugs/DB01276
Usage: For
Scientific Research Use Only, Not for Human Use.
Reference:
Peptides, Volume 37, Issue 1, September 2012, Pages
18-24
Molecular and Cellular Endocrinology.Volume 362, Issues 1–2, 15
October 2012, Pages 242–252
European Journal of Pharmacology, Volume 714, Issues 1–3, 15 August
2013, Pages 188-192
Biochemical and Biophysical Research Communications.Volume 434, Issue
1, 26 April 2013, Pages 150–154
European Journal of Pharmacology, Volume 699, Issues 1–3, 15 January
2013, Pages 106-111
Acta Biomaterialia, Volume 10, Issue 2, February 2014, Pages
812-820
Nuclear Medicine and Biology, Volume 40, Issue 8, November 2013,
Pages 1006-1012
Pharmacological Research, Volume 84, June 2014, Pages
18-25
Nuclear Medicine and Biology, Volume 41, Issue 6, July 2014, Pages
471-476
Regulatory Peptides, Volumes 190–191, May 2014, Pages
1-11